Article
Download the registration form and fax it back
Kalaris and AlloVir Inc. complete merger
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
Staying the course in shifting winds
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
How COVID-19 shifted ophthalmologist-patient communication
Ocugen to move forward with dosing of second cohort of phase 1 clinical trial of OCU200
